Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Sep 27, 2022; 14(9): 896-903
Published online Sep 27, 2022. doi: 10.4240/wjgs.v14.i9.896
Published online Sep 27, 2022. doi: 10.4240/wjgs.v14.i9.896
Central pancreatectomy (n = 34) | Distal pancreatectomy (n = 262) | P value | |
Gender | 0.627 | ||
Female, n (%) | 25 (73.5) | 182 (69.5) | |
Male, n (%) | 9 (26.5) | 80 (30.5) | |
Age (x ± s, yr) | 48 ± 13 | 52 ± 15 | 0.172 |
BMI (x ± s, kg/m2) | 22.4 ± 3.4 | 22.8 ± 3.6 | 0.545 |
Hypertension, n (%) | 7 (20.6) | 78 (29.8) | 0.266 |
Diabetes, n (%) | 2 (5.9) | 28 (10.7) | 0.568 |
Tumor size (x ± s, cm) | 3.2 ± 1.8 | 3.5 ± 2.1 | 0.433 |
Pathology, n (%) | < 0.005 | ||
SCN | 13 (38.2) | 48 (18.3) | |
IPMN | 4 (11.8) | 47 (17.6) | |
MCN | 1 (2.9) | 50 (19.1) | |
SPN | 13 (38.2) | 52 (19.8) | |
pNET | 3 (8.8) | 50 (19.1) | |
Median distance between the tumor and left-side border of the SMV (mm) | 8.9 (10.9) | 12.5 (11.4) | 0.076 |
Central pancreatectomy (n = 34) | Distal pancreatectomy (n = 262) | P value | |
Surgery, n (%) | < 0.005 | ||
Open surgery | 25 (73.5) | 63 (24.2) | |
Laparoscopy | 9 (26.5) | 197 (75.8) | |
Associated splenectomy, n (%) | 0 | 123 (46.9) | |
Mean operation time (min) | 311 | 244 | < 0.05 |
Mean perioperative blood loss (mL) | 159 | 167 | 0.525 |
Overall morbidity, n (%) | 0.370 | ||
I | 13 (38.2) | 91 (34.0) | |
II | 11 (32.4) | 95 (36.6) | |
IIIa | 2 (5.9) | 17 (6.5) | |
IIIb | 2 (5.9) | 3 (1.1) | |
IV | 0 (0) | 0 (0) | |
POPF grade, n (%) | 0.073 | ||
A | 15 (44.1) | 67 (25.6) | |
B | 10 (29.4) | 85 (32.4) | |
C | 0 (0) | 0 (0) | |
Chyle leakage, n (%) | 1 (2.9) | 15 (5.7) | 0.926 |
Delayed gastric emptying, n (%) | < 0.05 | ||
A | 9 (26.5) | 38 (14.5) | |
B | 1 (2.9) | 2 (0.8) | |
C | 0 (0) | 1 (0.4) | |
Postoperative bleeding | 0 (0) | 0 (0) | - |
Mean postoperative hospital stay (d) | 17 | 11 | 0.783 |
In-hospital mortality | 0 (0) | 0 (0) | - |
Readmission within 30 d | 0 (0) | 0 (0) | - |
Central pancreatectomy (n = 34) | Distal pancreatectomy (n = 262) | P value | |
Endocrine function | |||
New-onset or aggravated diabetes mellitus, n (%) | 0 (0) | 40 (15.3) | < 0.05 |
Exocrine function | |||
Diarrhea immediately after surgery | 2 (5.9) | 46 (17.6) | 0.059 |
Diarrhea 12 mo after surgery | 0 (0) | 25 (9.5) | < 0.05 |
- Citation: Chen YW, Xu J, Li X, Chen W, Gao SL, Shen Y, Zhang M, Wu J, Que RS, Yu J, Liang TB, Bai XL. Central pancreatectomy for benign or low-grade malignant pancreatic tumors in the neck and body of the pancreas. World J Gastrointest Surg 2022; 14(9): 896-903
- URL: https://www.wjgnet.com/1948-9366/full/v14/i9/896.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i9.896